期刊文献+

子宫内膜癌182例临床病例分析

Clinical Analysis of 182 Cases of Endometrial Cancer
下载PDF
导出
摘要 目的探讨子宫内膜样腺癌与非子宫内膜样癌患者的发病年龄、手术-病理分期、组织学分级、肌层侵犯、淋巴结转移情况及肿瘤组织雌孕激素受体表达的差异,为临床诊治提供客观依据。方法对182例子宫内膜癌患者的临床病理资料进行回顾性分析。结果非子宫内膜样癌与子宫内膜样腺癌的平均发病年龄分别为57.71±7.09、49.96±9.43岁;在已绝经患者中的比率分别为80.77%和63.46%;非子宫内膜样癌较子宫内膜样癌组织分化差,易于发生肌层浸润及淋巴结转移。结论非子宫内膜样癌与子宫内膜样腺癌相比,患者发病年龄偏大;深肌层浸润发生率高;肿瘤组织分化较差,雌孕激素受体阳性率明显低于子宫内膜样腺癌,且易发生淋巴结转移。
出处 《现代诊断与治疗》 CAS 2014年第9期1943-1945,共3页 Modern Diagnosis and Treatment
基金 2012年广东省建设中医药强省科研课题(20122095)
  • 相关文献

参考文献7

  • 1王晓迪,李小平,王建六,魏丽惠.435例子宫内膜癌综合治疗疗效分析[J].中国妇产科临床杂志,2013,14(4):295-299. 被引量:8
  • 2刘双.子宫内膜癌75例的临床与病理特点分析[J].中国医药指南,2012,10(12):447-448. 被引量:3
  • 3刘苏,谷丽萍,蔡明哲,董瑞丽,王俊芳,曹成成.子宫内膜癌455例临床病例分析[J].中国妇幼保健,2012,27(3):348-349. 被引量:2
  • 4南芳芳,魏双燕,刘艳妮,姜洁.子宫内膜癌126例临床病理与预后分析[J].现代妇产科进展,2011,20(10):799-802. 被引量:10
  • 5Rebecca Siegel,Deepa Naishadham,Ahmedin Jemal.Cancer statistics, 2013[J]. CA: A Cancer Journal for Clinicians . 2013 (1)
  • 6Ian Jacobs,Aleksandra Gentry-Maharaj,Matthew Burnell,Ranjit Manchanda,Naveena Singh,Aarti Sharma,Andy Ryan,Mourad W Seif,Nazar N Amso,Gillian Turner,Carol Brunell,Gwendolen Fletcher,Rani Rangar,Kathy Ford,Keith Godfrey,Alberto Lopes,David Oram,Jonathan Herod,Karin Williamson,Ian Scott,Howard Jenkins,Tim Mould,Robert Woolas,John Murdoch,Stephen Dobbs,Simon Leeson,Derek Cruickshank,Steven J Skates,Lesley Fallowfield,Mahesh Parmar,Stuart Campbell,Usha Menon.Sensitivity of transvaginal ultrasound screening for endometrial cancer in postmenopausal women: a case-control study within the UKCTOCS cohort[J].Lancet Oncology.2011(1)
  • 7Andrea Mariani,Sean C. Dowdy,Karl C. Podratz.New surgical staging of endometrial cancer: 20 years later[J].International Journal of Gynecology and Obstetrics.2009(2)

二级参考文献42

  • 1王志启,王建六,郭健,魏丽惠.内分泌辅助治疗子宫内膜癌的临床意义[J].中华医学杂志,2005,85(34):2414-2419. 被引量:21
  • 2朱海燕,赖爱鸾.绝经前后妇女子宫内膜癌120例临床分析[J].中国医刊,2007,42(2):37-39. 被引量:13
  • 3Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2008 [J]. CA Cancer J Clin,2008 ,58 :71-96.
  • 4Zusterzeel PL, Bekkers RL, Hendriks JC, et al. Prognostic factors for recurrence in patients with FIGO stage I and Ⅱ , intermediate or high risk endometrial cancer [ J ]. Acta Obstet Gynecol Scand ,2008,87 (2) :240-246.
  • 5Gadducci A, Cavazzana A, Cosio S, et al. Lymph-vascular space involvement and outer one-third myometrial invasion are strong predictors of distant haematogeneous failures in patients with stage Ⅰ- Ⅱ endometrioid-type endometrial cancer [ J ]. Anticancer Res, 2009,29 ( 5 ) : 1715-1720.
  • 6Banno K, Yanokura M, Kobayashi Y, et al. Endometrial cancer as a familial tumor:pathology and molecular carci- nogenesis (review) [ J ]. Curr Genomics, 2009,10 ( 2 ) : 127-132.
  • 7Takeshima N, Ota T, Omatsu K, et al. Postoperative adju- vant chemotherapy in surgically staged grade 3 endometri- al cancer[ J]. Anticancer Res ,2008,28 (3B) : 1785-1788.
  • 8Mundt AJ, Connell PP. Do conventional pathologic fea- tures lose their prognostic significance following postoper- ative radiation therapy in pathologic stage Ⅰ - Ⅱ endome- trial adenocarcinoma [ J ]. Int J Cancer, 2000,90 ( 4 ) : 224-230.
  • 9Morrow CP, Bundy BN, Kurman RJ, et al. Relationship be- tween surgical- pathological risk factors and outcome in clinical stage Ⅰ and Ⅱ carcinoma of the endometrium:a Gynecologic Oncology Group study [ J ]. Gynecol Oncol, 1991,40( 1 ) :55-65.
  • 10American Cancer Society. Cancer Facts and Figures 2007, Uterine Corpus ( endometrium ) [ R ]. Atlanta : A- merican Cancer Society,2007:21-21.

共引文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部